Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;97(2):e70234.
doi: 10.1002/jmv.70234.

Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter

Affiliations

Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter

Mathiew Hota et al. J Med Virol. 2025 Feb.

Abstract

The COVID-19 epidemic has shown regional variations in transmission and outcomes. As a primary hotspot in Chad, N'Djamena is crucial for comprehensive epidemiological investigation. Our study employed two methodologies: seroprevalence data collection and whole-genome sequencing of SARS-CoV-2 strains. This dual approach assessed population exposure and virus genetic diversity. Seroprevalence data indicated broader exposure than confirmed cases suggested, and genome sequencing identified multiple strains, including globally recognized variants of concern. Integrating these data provided insights into transmission dynamics, potential herd immunity thresholds, and the impact of specific variants on disease progression. Our findings underscore the importance of integrated, multidisciplinary research in infectious disease epidemiology and inform targeted public health strategies, including social measures and vaccination, to combat infectious diseases in N'Djamena.

Keywords: Chad; SARS‐CoV‐2; genomic surveillance; seroprevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Genetic diversity and sequencing statistics of SARS‐CoV‐2. The chart illustrates the percentage of the SARS‐CoV‐2 genome sequenced in relation to the RT‐qPCR Ct value for each of the 42 samples. Each circle represents a sequence recovered from an infected individual in Chad, with colors indicating lineage assignment.
Figure 2
Figure 2
Temporal distribution of SARS‐CoV‐2 variants in N'Djamena, Chad from November 2021 to January 2022.
Figure 3
Figure 3
Phylogenetic analysis of SARS‐CoV‐2 viral strains circulating in N'Djamena, Chad, between November 2021 and January 2022. A time‐resolved maximum‐likelihood tree of SARS‐CoV‐2, including novel isolates (n = 42) and representative worldwide subsample genomes (n = 3000) collected up to November 2022. The genomes are colored according to the lineages (VOC and ancestral lineages) as shown in the legend on the top left. The genomes generated in this study have been highlighted in the tree with circles: black circles represent genomes from patients with mild cases, while red circles represent genomes from patients with severe cases.

References

    1. Cosar B., Karagulleoglu Z. Y., Unal S., et al., “SARS‐CoV‐2 Mutations and Their Viral Variants,” Cytokine & Growth Factor Reviews 63 (2022): 10–22. - PMC - PubMed
    1. Farhud D. D. and Mojahed N., “SARS‐COV‐2 Notable Mutations and Variants: A Review Article,” Iranian Journal of Public Health 51 (2022): 14–94. - PMC - PubMed
    1. Seyed Alinaghi S. A., Mirzapour P., Dadras O., et al., “Characterization of SARS‐CoV‐2 Different Variants and Related Morbidity and Mortality: A Systematic Review,” European Journal of Medical Research 2 (2021): 6–190. - PMC - PubMed
    1. Cabore J. W., Karamagi H. C., Kipruto H. K., et al., “COVID‐19 in the 47 Countries of the WHO African Region: A Modelling Analysis of Past Trends and Future Patterns,” Lancet Global Health 10 (2022): e1099–e1114. - PMC - PubMed
    1. Tessema S. K. and Nkengasong J. N., “Understanding COVID‐19 in Africa,” Nature Reviews Immunology 21 (2021): 469–470. - PMC - PubMed

MeSH terms

Substances